Impact of perampanel on pharmacokinetics of concomitant antiepileptics in patients with partial‐onset seizures: pooled analysis of clinical trials

Abstract

Population PK data show that perampanel (2-12 mg/day, once daily at bedtime) has no relevant impact on the clearance of the most commonly used concomitant AEDs.